Changes to Medicare Advantage Plans in 2026

The year 2026 brings significant changes to Medicare Advantage Plans, enhancing benefits and protections for beneficiaries. One of the major updates includes new rules for dual-eligible special needs plans (D-SNPs), which will now require integrated identification cards and comprehensive health risk assessments.
These changes aim to streamline care and improve health outcomes for those enrolled in D-SNPs.
Additionally, provisions from the Inflation Reduction Act will be codified to ensure they remain effective beyond their original expiration. This includes measures to control prescription drug costs and enhance coverage options for beneficiaries.
Another important change is the requirement for Medicare Advantage plans to honor prior inpatient admission approvals, ensuring consistency in coverage decisions.
New regulations also address the appeals process, closing loopholes that previously allowed some adverse decisions to go unchallenged. This guarantees beneficiaries the right to appeal decisions regardless of when they occurred.
Together, these changes reflect a commitment to improving the Medicare Advantage landscape, making it more user-friendly and beneficial for enrollees.
Medicare Prescription Drug Coverage in 2026
Prescription drug coverage remains a critical component of Medicare Advantage Plans, and 2026 brings several important updates. Most Medicare Advantage Plans include Medicare Part D, eliminating the need for a separate drugs plan. This integration simplifies the process for beneficiaries, ensuring they have comprehensive coverage under one plan.
Notably, the average premium for plans offering prescription drug coverage will decrease from $13.32 in 2025 to $11.50 in 2026, making these plans more affordable for many. In addition, there will be a cap on out-of-pocket costs for insulin products, which will not exceed $35 for a one-month supply. These changes aim to make essential medications more accessible and affordable.
Another significant update is the elimination of deductibles for a range of adult vaccines, ensuring these important immunizations are available without upfront costs.
The annual cap on out-of-pocket prescription drug costs will be set at $2,100, providing further financial protection for beneficiaries. These changes reflect a broader effort to enhance prescription drug coverage and reduce the financial burden on Medicare beneficiaries.